Menu Search
Equities

OrbusNeich Medical Group Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6929:HKG.HS

OrbusNeich Medical Group Holdings Ltd

Actions
  • Price (HKD)3.66
  • Today's Change-0.03 / -0.81%
  • Shares traded14.50k
  • 1 Year change+1.95%
  • Beta--
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

OrbusNeich Medical Group Holdings Ltd is an investment holding company principally engaged in the development, production and sales of medical equipment and machineries. The Company is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The Company's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The Company mainly conducts its businesses in domestic and overseas markets.

  • Revenue in HKD (TTM)1.32bn
  • Net income in HKD317.86m
  • Incorporated2021
  • Employees1.43k
  • Location
    OrbusNeich Medical Group Holdings LtdUnits 303 & 305, 3/F Building 20E, Hong Hong KongHKG
  • Phone+852 28022288
  • Websitehttps://orbusneich.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.